Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Grant revenue	$ 88,161
Operating expenses:
Research and development	21,300,865	10,681,565
General and administrative	10,573,954	8,012,085
Total operating expenses	31,874,819	18,693,650
Loss from operations	(31,786,658)	(18,693,650)
Other income:
Other income	696,714
Interest income	51,232	126,416
Total other income	747,946	126,416
Net loss	$ (31,038,712)	$ (18,567,234)
Net loss per share, basic and diluted (in Dollars per share)	$ (1.25)	$ (0.91)
Weighted average common shares outstanding, basic and diluted (in Shares)	24,820,971	20,425,162
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
Net loss	$ (31,038,712)	$ (18,567,234)
Other comprehensive loss:
Foreign currency translation adjustments	2,617	(51,538)
Comprehensive loss	$ (31,036,095)	$ (18,618,772)